NO20034556L - Imidazotriazinon-holdige sammensetninger for nasal administrering - Google Patents

Imidazotriazinon-holdige sammensetninger for nasal administrering

Info

Publication number
NO20034556L
NO20034556L NO20034556A NO20034556A NO20034556L NO 20034556 L NO20034556 L NO 20034556L NO 20034556 A NO20034556 A NO 20034556A NO 20034556 A NO20034556 A NO 20034556A NO 20034556 L NO20034556 L NO 20034556L
Authority
NO
Norway
Prior art keywords
imidazotriazinone
containing compositions
nasal administration
nasal
administration
Prior art date
Application number
NO20034556A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034556D0 (no
Inventor
Peter Serno
Andreas Ohm
Wolfgang Barth
Richard-Josef Bauer
Hans-Martin Siefert
Dieter Zimmer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20034556D0 publication Critical patent/NO20034556D0/no
Publication of NO20034556L publication Critical patent/NO20034556L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20034556A 2001-04-12 2003-10-10 Imidazotriazinon-holdige sammensetninger for nasal administrering NO20034556L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10118306A DE10118306A1 (de) 2001-04-12 2001-04-12 Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
PCT/EP2002/003663 WO2002083674A2 (de) 2001-04-12 2002-04-03 Imidazotriazinonhaltige zusammensetzungen zur nasalen applikation

Publications (2)

Publication Number Publication Date
NO20034556D0 NO20034556D0 (no) 2003-10-10
NO20034556L true NO20034556L (no) 2003-12-10

Family

ID=7681379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034556A NO20034556L (no) 2001-04-12 2003-10-10 Imidazotriazinon-holdige sammensetninger for nasal administrering

Country Status (25)

Country Link
US (2) US6740306B2 (sk)
EP (1) EP1381368A2 (sk)
JP (1) JP2004525968A (sk)
KR (1) KR20030087072A (sk)
CN (1) CN1537004A (sk)
AR (1) AR035821A1 (sk)
BG (1) BG108245A (sk)
BR (1) BR0208813A (sk)
CA (1) CA2443639A1 (sk)
CZ (1) CZ20032752A3 (sk)
DE (1) DE10118306A1 (sk)
DO (1) DOP2002000373A (sk)
EC (1) ECSP034795A (sk)
EE (1) EE200300501A (sk)
GT (1) GT200200070A (sk)
HU (1) HUP0303877A3 (sk)
IL (1) IL158255A0 (sk)
MX (1) MXPA03009314A (sk)
NO (1) NO20034556L (sk)
PE (1) PE20021035A1 (sk)
PL (1) PL363033A1 (sk)
RU (1) RU2003133143A (sk)
SK (1) SK12682003A3 (sk)
UY (1) UY27256A1 (sk)
WO (1) WO2002083674A2 (sk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4540295B2 (ja) * 2001-05-09 2010-09-08 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト ２−フェニル置換イミダゾトリアジノンの新しい用途
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
CN101083984B (zh) * 2004-12-23 2010-11-10 罗克斯罗制药公司 用于经鼻内投与酮咯酸（ketorolac）的治疗组合物
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
EP1898879A1 (en) * 2005-06-23 2008-03-19 Schering Corporation Rapidly absorbing oral formulations of pde5 inhibitors
SG166106A1 (en) * 2005-09-29 2010-11-29 Bayer Schering Pharma Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
WO2008151734A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
KR20110017433A (ko) * 2008-06-13 2011-02-21 록스로 파마 인코퍼레이티드 비강내 투여용 케토로락의 약학적 제형물
US8551454B2 (en) * 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8277781B2 (en) * 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2020006606A1 (en) * 2018-07-05 2020-01-09 Helium 3 Resources Pty Ltd A pharmaceutical composition and method of use of same
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
IL298432A (en) * 2020-05-26 2023-01-01 Strategic Drug Solutions Inc Formulations and methods for treating erectile dysfunction

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
EP0985671B1 (en) 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
WO1998053819A1 (fr) * 1997-05-29 1998-12-03 Mochida Pharmaceutical Co., Ltd. Agent therapeutique destine a traiter l'anerection
AU9214498A (en) 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
HU230154B1 (hu) 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
WO2000000199A1 (en) * 1998-06-26 2000-01-06 Nastech Pharmaceutical Company, Inc. Nasal delivery of sildenafil citrate
CN1149983C (zh) * 1998-12-14 2004-05-19 赛勒吉药物股份有限公司 用于治疗肛门直肠病的组合物和方法

Also Published As

Publication number Publication date
UY27256A1 (es) 2002-11-29
IL158255A0 (en) 2004-05-12
DOP2002000373A (es) 2002-11-30
HUP0303877A3 (en) 2005-05-30
JP2004525968A (ja) 2004-08-26
HUP0303877A2 (hu) 2004-03-29
WO2002083674A3 (de) 2003-01-09
SK12682003A3 (sk) 2004-03-02
EE200300501A (et) 2003-12-15
NO20034556D0 (no) 2003-10-10
WO2002083674A2 (de) 2002-10-24
AR035821A1 (es) 2004-07-14
ECSP034795A (es) 2003-12-01
BG108245A (en) 2005-01-31
CA2443639A1 (en) 2002-10-24
KR20030087072A (ko) 2003-11-12
EP1381368A2 (de) 2004-01-21
US20040248891A1 (en) 2004-12-09
GT200200070A (es) 2003-01-31
CZ20032752A3 (cs) 2004-01-14
DE10118306A1 (de) 2002-10-17
PL363033A1 (en) 2004-11-15
MXPA03009314A (es) 2004-03-10
PE20021035A1 (es) 2002-11-29
RU2003133143A (ru) 2005-04-10
US20030022894A1 (en) 2003-01-30
US6740306B2 (en) 2004-05-25
BR0208813A (pt) 2004-03-09
CN1537004A (zh) 2004-10-13

Similar Documents

Publication Publication Date Title
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20033556L (no) Farmasöytiske formuleringer
EE200300523A (et) Aripiprasooli ravimlahus peroraalseks manustamiseks
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
NO20033384L (no) Farmasoytisk formulering
EE200300416A (et) Ravimvorm
ITMI20010748A0 (it) Composizioni farmaceutiche
IS7051A (is) Lyfjasamsetningar
NO20035627D0 (no) Farmasöytisk formulering
NO20034556L (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
NO20026123L (no) Farmasöytiske sammensetninger
DE50209245D1 (de) Neuroprotektives medikament
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
FI20022128A (fi) Farmaseuttinen koostumus
NO20031095D0 (no) Farmasöytiske sammensetninger
NO20020524L (no) Stabiliserte organisk-peroksid sammensetninger
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
EE200200689A (et) Ravimkoostised
FI5468U1 (fi) Farmaseuttinen koostumus
NO20041236L (no) Farmasoytisk formulering
SE0100847D0 (sv) Novel pharmaceutical composition
DK1330280T3 (da) Lægemiddelinhalator
FIU20010053U0 (fi) Suutinputki-ratkaisu

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application